Marian Evatt, MD, MS

Sponsored Research Projects

• A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled 14-week Study of DS-5565 in Chinese Patients With Diabetic Peripheral Neuropathic Pain
• A Phase 3, 12-week, Double-Blind, Placebo-Controlled, Randomized, Multicenter Study to Evaluate the Efficacy of Oral Istradefylline 20 and 40 mg/Day as Treatment for Subjects With Moderate to Severe Parkinson's Disease
• A Phase 3, Long-term, Open-label Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
• Clinical Coordination Center for STEADY-PD Phase 3 Study
• CVT-301-004: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study
• NBI-98854 for the Treatment of Tardive Dyskinesia - Phase 3